There are dozens of reasons to join us in Chicago April 22-23 for the 11th annual MidAmerica Healthcare Venture Forum. The conference unites active investors with corporate business development executives to facilitate investment opportunities with promising Midwest-based startups.
The Midwest is playing an ever-increasing role in bringing the latest technology and emerging innovations to the investment community. MidAmerica Healthcare Venture Forum was started to showcase dealflow originating in the Midwest and has grown to be the most influential forum of its type.
Here are 10 of the most powerful reasons you won’t want to miss this pivotal event. Or, if you’re already convinced, register now to take advantage of our Extreme Early Bird rates.
This important conference will be your opportunity to:
- Meet and connect with cream-of-the-crop early-stage startups, business development execs and active investors
- Discover investment opportunities and up-to-the-minute trends in healthcare
- Share ideas and make connections with venture capitalists and angel investors
- Learn about important new research on the state of healthcare venture capital and investing and the outlook for 2014
- Hear presentations from 30 of the most promising up-and-coming healthcare startups
- Attend receptions and luncheons with leading healthcare experts and innovative thought leaders
- Participate in Q&A panel discussions with prominent industry players
- Take part in a unique special session broadcast live focusing on opportunities with crowdfunding and The Jobs Act
- Meet potential collaborators and partners and expand your professional network
- Interact with the thriving healthcare technology and innovation community that characterizes the Midwest
We’re offering tickets now at the lowest price — save $300 on tickets now through February 2.
This year, MedCity has partnered with the Mid-America Healthcare Investors Network which has hosted the event for nearly 10 years and now is gathering promising Midwest-based startups from the medical device, diagnostics, health IT and biotech sectors with investors, venture capitalists, angels and beyond.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
I urge you to attend. We’re putting together panel discussions, keynotes and fireside chats and there will be startup presentations from 30 of the “Best of the Midwest” companies. If you are a startup and wish to apply, please do so here.
The event already has sponsors including the likes of GE Capital Healthcare Financial Services, Armentum Partners, Capital Royalty and StoneArch. Find out more about MidAmerica Healthcare Venture Forum and how you can get involved in the event.
This is your best opportunity to make connections and discover the importance of the Midwest in the future of healthcare. And now is your best opportunity to register and get our best rate, a savings of $300.
